Literature DB >> 14504564

Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia.

Brian Kirkpatrick1, Nidia C Messias, Robert R Conley, Rosalinda C Roberts.   

Abstract

An increased density of neurons in the white matter of the neocortex has been found in schizophrenia, and the original reports suggested this abnormality was restricted to a subgroup of patients. In a study of the inferior parietal cortex, we found that deficit schizophrenia subjects, but not nondeficit subjects, had an increased density of ICWMs. We extended that finding by comparing the density of microtubule-associated protein 2-immunoreactive ICWMs in deficit schizophrenia (N = 3), nondeficit schizophrenia (N = 4), and control (N = 5) subjects, using postmortem tissue from the dorsolateral prefrontal cortex (Brodmann area 46). The deficit group differed significantly from the other two groups; the respective mean (SD) density values for the deficit, nondeficit, and control groups were 1.27 (.10),.53 (.39), and.76 (.20) cells per 10-6 cubic microns. These group differences provide further evidence that deficit and nondeficit schizophrenia differ in their pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504564     DOI: 10.1097/01.nmd.0000087181.61164.e1

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  39 in total

1.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

2.  Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia.

Authors:  Stefano Marenco; Jason L Stein; Antonina A Savostyanova; Fabio Sambataro; Hao-Yang Tan; Aaron L Goldman; Beth A Verchinski; Alan S Barnett; Dwight Dickinson; José A Apud; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

Authors:  William R Keller; Bernard A Fischer; William T Carpenter
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

4.  Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Authors:  Hans-Gert Bernstein; Esther Jauch; Henrik Dobrowolny; Christian Mawrin; Johann Steiner; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-28       Impact factor: 5.270

Review 5.  The application of DTI to investigate white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Robert W McCarley; Martha E Shenton
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 6.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 7.  Early history of subplate and interstitial neurons: from Theodor Meynert (1867) to the discovery of the subplate zone (1974).

Authors:  Miloš Judaš; Goran Sedmak; Mihovil Pletikos
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

8.  Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.

Authors:  Yang Yang; Samantha J Fung; Alice Rothwell; Si Tianmei; Cynthia Shannon Weickert
Journal:  Biol Psychiatry       Date:  2010-10-25       Impact factor: 13.382

9.  An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

Authors:  Brian Kirkpatrick; Özlem Gürbüz Oflezer; Mehtap Delice Arslan; Gary Hack; Emilio Fernandez-Egea
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

10.  Will the Kraepelinian dichotomy survive DSM-V?

Authors:  Bernard A Fischer; William T Carpenter
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.